These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 83018)
61. Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema. Kawakami A; Eguchi K; Matsuoka N; Tsuboi M; Urayama S; Kawabe Y; Tahara K; Ishikawa N; Ito K; Nagataki S Clin Exp Immunol; 1997 Dec; 110(3):434-9. PubMed ID: 9409648 [TBL] [Abstract][Full Text] [Related]
62. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy. Yin X; Latif R; Bahn R; Tomer Y; Davies TF Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838 [TBL] [Abstract][Full Text] [Related]
63. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy. Kung AW; Lau KS; Kohn LD J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791 [TBL] [Abstract][Full Text] [Related]
64. Association of hypergammaglobulinemia G with HLA-DR3 in Graves' disease. Briones-Urbina R; Bear JC; Farid NR Tissue Antigens; 1982 Jan; 19(1):20-4. PubMed ID: 6896102 [TBL] [Abstract][Full Text] [Related]
65. Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. Roman SH; Greenberg D; Rubinstein P; Wallenstein S; Davies TF J Clin Endocrinol Metab; 1992 Mar; 74(3):496-503. PubMed ID: 1740483 [TBL] [Abstract][Full Text] [Related]
66. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336 [TBL] [Abstract][Full Text] [Related]
67. IgG thyrotrophin receptor antibody activity in Graves' disease; a study of TSH agonist and antagonist activities by isoelectric focusing. Creagh FM; Howells RD; Williams S; Didcote S; Hashim FA; Petersen VB; Rees Smith B Clin Endocrinol (Oxf); 1986 Jan; 24(1):79-88. PubMed ID: 3011318 [TBL] [Abstract][Full Text] [Related]
68. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease. Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751 [TBL] [Abstract][Full Text] [Related]
69. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay. Inui T; Kouki T; Yamashiro K; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A Thyroid; 1998 Apr; 8(4):319-25. PubMed ID: 9588497 [TBL] [Abstract][Full Text] [Related]
71. Prediction of outcome in Graves' disease after carbimazole treatment. Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484 [TBL] [Abstract][Full Text] [Related]
72. The HLA-DQ associations with Graves' disease in Chinese children. Wong GW; Cheng SH; Dorman JS Clin Endocrinol (Oxf); 1999 Apr; 50(4):493-5. PubMed ID: 10468909 [TBL] [Abstract][Full Text] [Related]
73. HLA antigens in Asian Indian patients with Graves' disease. Tandon N; Mehra NK; Taneja V; Vaidya MC; Kochupillai N Clin Endocrinol (Oxf); 1990 Jul; 33(1):21-6. PubMed ID: 2401095 [TBL] [Abstract][Full Text] [Related]
74. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease]. Lacka K; Kordel M; Gembicki M Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567 [TBL] [Abstract][Full Text] [Related]
75. Studies of possible antiidiotypic control mechanisms in Graves' disease. Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588 [TBL] [Abstract][Full Text] [Related]
76. Graves' disease: immunological and immunogenetic indicators of relapse. de Bruin TW; Bolk JH; Bussemaker JK; Stijnen T; Schreuder GM; de Vries RR; van der Heide D Br Med J (Clin Res Ed); 1988 May; 296(6632):1292-5. PubMed ID: 3133054 [TBL] [Abstract][Full Text] [Related]
77. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease. Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017 [TBL] [Abstract][Full Text] [Related]